Disparities in risk of and survival from oropharyngeal squamous cell carcinoma

Silverman, 1998 1998 SEER Cancer Statistics Review. Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. Cancer Statistics Review, 1973-1999. Bethesda (MD): National Cancer Institute. Available from: URL:http://seer.cancer.gov/csr/1973_1999/sections.html#sections Blot, 1988, Smoking and drinking in relation to oral and pharyngeal cancer, Cancer Res, 48, 3282 Mashberg, 1981, Alcohol as a primary risk factor in oral squamous cell carcinoma, CA Cancer J Clin, 31, 146, 10.3322/canjclin.31.3.146 Maden, 1992, Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men, Am J Epidemiol, 135, 1093, 10.1093/oxfordjournals.aje.a116209 Miller, 1996, Human papillomavirus expression in oral mucosa, oral premalignant conditions and squamous cell carcinoma. A retrospective review of the literature, Oral Surg Oral Med Oral Pathol, 82, 57, 10.1016/S1079-2104(96)80378-7 Silverman, 1988, Early diagnosis of oral cancer, Cancer, 62, 1796, 10.1002/1097-0142(19881015)62:1+<1796::AID-CNCR2820621319>3.0.CO;2-E Scully, 2000, Ethnicity and oral cancer, Lancet Oncol, 1, 37, 10.1016/S1470-2045(00)00008-5 Satcher, 2000, Surgeon General's report on oral health, Public Health Rep, 115, 115, 10.1093/phr/115.5.489 Jovanovic, 1993, Tobacco and alcohol related to the anatomical site of oral squamous cell carcinoma, J Oral Pathol Med, 22, 459, 10.1111/j.1600-0714.1993.tb00125.x Mashberg, 1976, Anatomical site and size of 222 early asymptomatic oral squamous cell carcinomas: a continuing prospective study of oral cancer. II, Cancer, 37, 2149, 10.1002/1097-0142(197605)37:5<2149::AID-CNCR2820370502>3.0.CO;2-G Census Bureau Day, 1993, Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco and other determinants, J Natl Cancer Inst, 85, 465, 10.1093/jnci/85.6.465 Mashberg, 1993, Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans, Cancer, 72, 1369, 10.1002/1097-0142(19930815)72:4<1369::AID-CNCR2820720436>3.0.CO;2-L Boffetta, 1992, Carcinogenic effect of tobacco smoking and alcohol drinking on anatomic sites of the oral cavity and oropharynx, Int J Cancer, 52, 530, 10.1002/ijc.2910520405 Merletti, 1989, Role of tobacco and alcoholic beverages in the etiology of cancer of the oral cavity/oropharynx in Torino, Italy, Cancer Res, 49, 4919 Silverman, 2001, Demographics and occurrence of oral and pharyngeal cancers: the outcomes, the trends, the challenge, J Am Dent Assoc, 132, 7S, 10.14219/jada.archive.2001.0382 Marcus, 1989, Use of smokeless tobacco in the United States: recent estimates from the current population survey, NCI Monogr, 8, 17 Noland, 1990, Use of snuff, chewing tobacco, and cigarettes among adolescents in a tobacco-producing area, Addict Behav, 15, 517, 10.1016/0306-4603(90)90052-Y Vigneswaran, 1995, Tobacco use and cancer. A reappraisal, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 80, 178, 10.1016/S1079-2104(05)80199-4 Bouquot, 1998, Oral cancer in a tobacco-chewing US population: no apparent increased incidence or mortality, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 86, 697, 10.1016/S1079-2104(98)90207-4 Zavras, 2001, Smoking and alcohol in the etiology of oral cancer: gender-specific risk profiles in the south of Greece, Oral Oncol, 37, 28, 10.1016/S1368-8375(00)00060-9 Perez, 1998, Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcome, Int J Radiat Oncol Biol Phys, 42, 1077, 10.1016/S0360-3016(98)00291-0 1997, MMWR Morb Mortal Wkly Rep, 46, 444 Hay, 2002, Oral cancer risk perception among participants in an oral cancer screening program, Cancer Epidemiol Biomarkers Prev, 11, 155 Eberhart, 1994, Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology, 107, 11183, 10.1016/0016-5085(94)90246-1 Sheehan, 1999, The relationship between cyclooxygenase-2 expression and colorectal cancer, J Am Med Assoc, 282, 1254, 10.1001/jama.282.13.1254 Oshima, 1996, Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2), Cell, 87, 803, 10.1016/S0092-8674(00)81988-1 Kawamori, 1998, Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis, Cancer Res, 58, 409 Morgan, 1997, Deleterious effects of prostaglandin E2 in oesophageal carcinogenesis, Med Hypotheses, 48, 177, 10.1016/S0306-9877(97)90285-1 Kune, 1988, Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study, Cancer Res, 48, 4340 Marnett, 1992, Aspirin and the potential role of prostaglandins in colon cancer, Cancer Res, 52, 5575 Thun, 1992, Risk factors for fatal colon cancer in a large prospective, J Natl Cancer Inst, 84, 1491, 10.1093/jnci/84.19.1491 Heath, 1994, Nonsteroidal antiinflammatory drugs and human cancer. Report of an interdisciplinary research workshop, Cancer, 74, 2885, 10.1002/1097-0142(19941115)74:10<2885::AID-CNCR2820741023>3.0.CO;2-P Farrow, 1998, Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer, Cancer Epidemiol Biomarkers Prev, 7, 97 Funkhouser, 1995, Aspirin and reduced risk of esophageal carcinoma, Cancer, 76, 1116, 10.1002/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I 1997, MMWR Morb Mortal Wkly Rep, 46, 498